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Salivary secretory immunoglobulin A (sIgA) is the 
predominant immunoglobulin in saliva and other mucosal 
secretions. It plays an important role in mucosal immunity 
and has therefore been described as a first line of defense 
against pathogens and antigens presented at the mucosa, 
such as cold-causing viruses.1,2 While a number of studies 
have found no relationships between upper respiratory 
symptoms (URS) and sIgA,3,4 longer-lasting longitudinal 
studies have been able to associate preceding decreased 
resting levels of sIgA with URS.5,6 Consequently, sIgA 
has been suggested to be a clinical biomarker to predict 
incidence of URS.5 This is of practical relevance, as URS 
are among the most common medical problems in elite 
able-bodied athletes.7 URS may lead to missed training 
sessions and compromises in athletic performance. Fur-
thermore, according to some surveys, sore throats and 
flulike symptoms are more common in athletes than in 
the general population, and, once athletes are infected, 
their colds may last longer.8
Positive relationships between URS incidence and 
high training loads have been found in athletic able- 
bodied5 and paraplegic9 populations. Furthermore, 
negative relationships between training load and sIgA 
concentration or training load and sIgA secretion rate 
have been documented previously.5,6 In this context, it is 
important to know that during periods of heavy training, 
the sympathovagal balance at rest seems to be altered, 
with a rise in sympathetic and suppression of parasym-
pathetic drive.10 Both parasympathetic and sympathetic 
nerve stimulation can modify saliva composition and 
sIgA secretion.11 This may lead to the conclusion that 
high training loads, altered sympathovagal balance, 
depressions in sIgA concentration or sIgA secretion rate, 
and a higher incidence of URS are causally connected.
Since the sympathetic outflow in tetraplegic indi-
viduals is decreased,12 any stress-related sIgA response 
at rest has the potential to be altered in comparison with 
populations with intact autonomic innervation. How-
ever, this issue has not been investigated until present. 
This would be of particular relevance, as spinal-cord-
injured individuals are prone to respiratory diseases 
such as dyspnea, pneumonia, or respiratory failure.13 
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In a sporting context, it should be noted that in line with 
findings in able-bodied athletes,7 anecdotal evidence 
from the national governing sports bodies’ training-log 
records shows a high proportion of URS-related dropouts 
in athletic tetraplegic populations during heavy training 
periods and competition.
Knowledge of oral-respiratory mucosal immune 
responses to exercise in tetraplegic athletes could serve 
as a base for health promotion and monitoring in this 
specific population. Indeed, we recently found a com-
pensatory effect on sIgA responses to acute exercise in 
elite tetraplegic athletes.14 Therefore, the purpose of this 
study was to examine resting sIgA responses as a function 
of training load and episodes of URS during a 5-month 
training period in tetraplegic athletes.
Methods
Participants
Fourteen tetraplegic wheelchair rugby players (referred 
to as participants A–N throughout the article) volunteered 
to participate in this study, which was approved by the 
university’s ethics committee. The group consisted of 13 
men and 1 woman (participant I) who were all members 
of the Great Britain wheelchair rugby squad. A summary 
of their physical, physiological, and sport characteristics 
is presented in Table 1.
Data Collection
Data were collected at 12 predefined time points over 
5 months during the squad’s training building up to 
the World Championships in September 2010 (Figure 
1). Timed, unstimulated saliva samples were collected 
between 2 and 5 minutes (depending on the individu-
als’ saliva flow rate) into sterile plastic containers. For 
this, participants rinsed their mouth with water and sat 
still with their head slightly tilted forward with minimal 
orofacial movement. All samples were collected before 
11 AM in a fasted state and before any physical activity. 
Samples were stored on ice immediately after collection 
and stored at –20°C within 6 hours.
On each data-collection day, participants filled out 
exercise questionnaires in retrospect; a sample question-
naire was provided for guidance. For each day individu-
ally, average intensity for any given exercise (such as 
individual workouts or game play) was rated on a 5-point 
scale (1 = very low, 2 = low, 3 = medium, 4 = hard, 5 
= very hard), and exercise duration was noted. Training 
load was then determined by multiplying intensity by 
duration,15 and a rolling average over 7 days was com-
puted for the entire duration of the study (Figure 1). The 
100% training load for each individual was defined as 
the highest 7-day average attained during the 5-month 
study period. Finally, the location of the athletes and any 
sport-related international travels were recorded.
Illness questionnaires were also filled out in retro-
spect. The criteria for definition of an episode of URS 
have been published elsewhere.16 In short, the self-
reported occurrence of symptoms like sore or scratchy 
throat, runny/plugged nose, cough, or fever was noted and 
their intensity was rated on a 3-point scale (1 = light, 2 
= moderate, 3 = severe). Multiplying the intensity score 
by the number of symptoms and the number of days suf-
fered, a minimum score of 12 was taken to indicate that 
a URS was present. Finally, according to the methods 
employed by Neville et al,6 participants used a 3-point 
scale to indicate their resting status on the day of data 
collection (worse than, same as, or better than normal).
With the exception of 4 dates (April 20, May 11, June 
23, and August 10), data were collected on scheduled 
training days at the training venue. When participants 
were unable to attend these sessions, as well as on the 
dates mentioned before, saliva samples were collected 
individually by the participants. Detailed written instruc-
tions were provided, and we ensured that procedures for 
correct sample storing were in place.
Analytical Methods
For analysis, samples were defrosted and weighed to the 
nearest 10 mg. Saliva volume was estimated assuming 
Table 1 Participant Characteristics
Parameter Value
Body mass, kg 70.4 ± 13.2
Height, m 1.81 ± 0.12
Age, y 33 ± 5
Lesion level C6–C7
Motor completeness of injury
 yes n = 13 
 no n = 1
Time since onset of disability, y 12 ± 5
Wheelchair rugby classification 0.5—2.5
Training, h/wk 14 ± 3
Apart from lesion level and wheelchair rugby classification (range), 
numbers are average ± SD.
Figure 1 — Study design. Training load is given for an example 
participant.
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saliva density to be 1.00g/mL,17 and saliva flow rate 
was calculated from saliva volume and collection time. 
Samples were then spun for 2 minutes at 13,400 rpm. 
sIgA concentration was determined through a sandwich 
ELISA, using flat-bottomed microtitration plates (Nunc-
Immunoplate, Thermo Fisher Scientific, Denmark). After 
the plates were coated with rabbit anti-human-capture 
antibody (Dako UK, Ely, UK), they were washed and 
blocked with a blocking protein solution (2.0% bovine 
serum albumin in phosphate-buffered saline). Depend-
ing on saliva flow rate, saliva samples were diluted in 
phosphate-buffered saline by 1:375 to 1:1500 (samples 
with a lower flow rate were diluted by a higher factor). 
Purified IgA from colostrum was used as a standard 
(Sigma-Aldrich, St Louis, MO). Duplicate samples of 
50 μL were applied to the plates, which were incubated 
overnight at 4°C. After the plates were washed, detec-
tion antibody (Dako UK, Ely, UK) was applied and 
plates were incubated at 25°C for 90 minutes. After a 
final wash, a coloring substrate (OPD substrate, Dako 
UK) was added, and the absorbance of the individual 
samples was determined spectrophotometrically at 490 
nm (Opsys MR, Dynex Technologies Inc, Chantilly, VA). 
sIgA secretion rate was calculated by multiplying sIgA 
concentration by saliva flow rate.
All saliva samples from each participant were ana-
lyzed in duplicate on 1 microplate. The coefficient of 
variation (CV) of this method based on analyses of these 
duplicate samples was 2.8% ± 2.7%.
Data Processing  
and Statistical Analyses
The PASW 18.0 statistical package (SPSS Inc, Chicago 
IL) was used for all statistical analyses. Means and 
standard deviations were computed for normally distrib-
uted variables, and medians and quartiles for all other 
variables. Furthermore, CVs were calculated. For each 
sample, salivary data (sIgA secretion rate and concentra-
tion) were then matched to the individual average 7-day 
training load before sample collection. A logarithmic 
transformation was applied to these salivary data to weigh 
increases by a certain factor the same as decreases by 
the same factor. Slopes of the linear regression of the 
log-transformed salivary data versus individual training 
load were calculated for each participant individually, 
and the slopes were tested with a Wilcoxon statistic 
against a fixed value of zero; a Bonferroni correction was 
applied for multiple comparisons. The same procedure 
was applied to the relationships between saliva flow rate 
versus sIgA concentration and saliva flow rate versus 
sIgA secretion rate.
Furthermore, median salivary data were compared 
between participants contracting at least 1 URS and par-
ticipants not contracting at least 1 URS during the study 
period, using the Mann–Whitney test. Finally, all salivary 
data were pooled, expressed as a percent deviation from 
the individual median, and analyzed with Mann–Whitney 
tests to explore the impact of URS occurrence within 
2 weeks after sample collection on salivary data. The 
same procedures were applied to investigate the impact 
of resting status on salivary data; however, due to the 
low occurrence of samples with a rating of better than 
normal (n = 3), these samples were excluded from this 
analysis. Statistical significance for all analyses was 
accepted at P < .05.
Results
Over the 5-month study period, 127 saliva samples were 
collected. The within-individual variability of sIgA secre-
tion rate was high, with a mean CV of 54%; the CV for 
between-individuals variability was 76% (Figure 2). The 
CVs for sIgA concentration were 55% (within individual) 
and 88% (between individuals). Eighty percent of the 
sIgA secretion-rate data of participants D (incomplete 
spinal-lesion level) and I (female) were found to be within 
the 10th to 90th percentiles of the studied population, 
which was male with a complete spinal-lesion level. 
Therefore, their data were entered for all analyses.
A significant negative relationship was found 
between sIgA secretion rate and individual training load, 
with the average slope of the individual regression lines 
differing significantly from zero (P = .04, Figure 3). 
However, on average, training load accounted for only 
8% (quartiles: 4,18) of the variance. Furthermore, a trend 
was found between training load and sIgA concentration 
(P = .06), again accounting for 8% (quartiles: 2,20) of 
the variance.
A negative relationship was found between indi-
vidual saliva flow rate and sIgA concentration, with the 
average slope of the individual regression lines differing 
significantly from zero (P = .002, Figure 4). Furthermore, 
negative but nonsignificant relationships were detected 
when comparing average data of saliva flow rate and sIgA 
concentration between participants (P = .43, Figure 4). 
Finally, no significant relationship between individual 
saliva flow rate and sIgA secretion rate was found (P 
= .72).
Three players reported at least 1 episode of URS 
during the study period (participants A, F, and K). How-
ever, their median sIgA secretion rate did not differ from 
that of the other players (P = .19, Figure 2). Furthermore, 
sIgA responses did not differ between samples with no 
subsequent episode of URS and samples with a subse-
quent episode of URS within 2 weeks (P > .05). Likewise, 
no differences in sIgA responses were found when com-
paring samples of the different resting status ratings (P 
> .05, Table 2). Finally, over the 5-month study period, 
players spent 20 ± 12 days abroad for competitions and 
used planes for transportation on 6.1 ± 3.7 occasions.
Discussion
The main finding of this study is that resting sIgA secre-
tion rate is associated with training load in tetraplegic 
athletes, which is in line with findings in able-bodied 
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Figure 2 — Resting salivary immunoglobulin A (sIgA) secretion rate, sIgA concentration, and saliva flow rate over the 5-month 
study period. A–N are participant codes. Participants A, F, and K contracted at least 1 episode of upper respiratory symptoms during 
the study period. Values are displayed as box plots showing median, quartiles, and minimum/maximum.
athletes.4,6 However, we currently cannot confirm a 
relationship between decreased sIgA responses and the 
occurrence of subsequent URS. We further found saliva 
flow rate to explain some of the variation observed in 
sIgA concentration on an intraindividual basis.
It is commonly accepted that the sympathetic ner-
vous system may at least partly be responsible for the 
changes in salivary markers such as sIgA2,18 and that both 
sympathetic and parasympathetic stimulation result in 
increased sIgA secretion.11 Tetraplegic individuals rep-
resent a model with no centrally mediated sympathetic 
nervous control,19 as centrally mediated sympathetic 
stimuli do not activate the decentralized part of the ner-
vous system below the level of lesion.20 Furthermore, 
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salivary gland innervation originates from the upper 
thoracic segments and is therefore disrupted in tetraplegic 
individuals.11 Therefore, it is important to note that with 
respect to salivary gland function, the studied population 
is distinctively different than the able-bodied populations 
studied earlier. However, it seems that these differences 
in tetraplegic athletes do not have a major impact on 
resting sIgA secretion rate and sIgA concentration when 
compared with the able-bodied population. Even though 
between- and within-subject variability of sIgA responses 
Figure 3 — Resting salivary immunoglobulin A (sIgA) secretion rate versus individual training load over the 5-month study period, 
data points and individual regression lines. A–N are participant codes; circles, samples with no subsequent upper respiratory symp-
toms (URS); ×, samples with subsequent URS.
Figure 4 — Resting salivary immunoglobulin A (sIgA) concentration versus saliva flow rate over the 5-month study period, data 
points and linear regression lines. A–N are participant codes; circles, raw data; Δ (top right panel), average data shown for all individu-
als. Note the different scale of the x-axes in the top and bottom charts and the presentation of sIgA concentration on a logarithmic 
scale, which leads to a distortion of linear regression lines.
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were high, they were in a range and of a variability 
similar to those of able-bodied athletes.6 We therefore 
suggest that the main modulation of resting sIgA is likely 
to stem from variations in parasympathetic activity, as 
this remains normal in tetraplegic individuals19 and has 
been shown to be related to periods of heavy exercise.10 
Another possible modulator is sympathetic reflex activity, 
which may be triggered by circulating metabolites related 
to stress or fatigue.21 Since this reflex activity is still intact 
in the tetraplegic population, it results in a remaining, but 
qualitatively altered, neural function.21 This is supported 
by the suggestion that sympathetic reflex activity may be 
a reason for the qualitatively altered sIgA response after 
acute exercise in this population.14
It should be noted that the participants in this study 
were highly trained. The training loads we observed in 
this population were comparable to those observed previ-
ously in able-bodied participants in studies investigating 
sIgA responses to chronic exercise.3,4,6 In contrast, many 
studies on tetraplegic populations reporting depressed 
markers of immunity have been conducted in patient and/
or marginally trained populations.22,23 It must therefore be 
considered that long-term training in tetraplegic individu-
als may have a positive impact on these markers, through 
mechanisms like sympathetic reflex activity,21 which may 
be enhanced as a result of chronic exercise.
This study cannot confirm a cause-and-effect rela-
tionship between low sIgA responses and subsequent 
URS. However, the negative relationship between train-
ing load and sIgA secretion rate may explain some of 
the increase in URS after periods of hard training, as 
previously observed in both spinal-cord-injured9 and 
able-bodied athletes.24 Based on the impairments of the 
tetraplegic population, we conclude that the impact of 
exercise on sIgA secretion rate seems not to be influ-
enced by sympathetic central drive, but we again sug-
gest parasympathetic and sympathetic reflex activity as 
possible modulators. On the other hand, we do not rule 
out that underlying reasons for the lack of a relationship 
between sIgA responses and the occurrence of URS may 
include the altered sympathetic outflow in this specific 
population. However, it is important to note that even 
though relationships between sIgA responses and URS 
occurrence have been shown in able-bodied populations,6 
this finding was not confirmed in other studies.3,4 We 
therefore conclude that this relationship is not clear and 
potentially blurred by the additional stresses required 
for the occurrence of URS. It has been suggested earlier 
that the relationship between exercise and URS is affected 
by poorly known individual determinants such as genetic 
factors, fitness, and nutritional status.25 Factors concealing 
a clear relationship may further include pathogen exposure, 
environmental factors, or psychological strategies,26 which 
were not controlled for in the current study and there-
fore potentially differed between participants. We may 
also add that the studied athletes spent a considerable 
amount of time abroad due to their sport and therefore 
used planes for transportation rather frequently, which 
may represent additional stressors.27 As a final point, it 
should also be acknowledged that the presence of URS is 
not necessarily indicative of the presence of upper respira-
tory tract infection and may reflect airway inflammation 
rather than viral or bacterial infection.28 Nevertheless, 
regardless of cause, the deleterious effects of URS on 
training and competition are of main concern to athletes 
and coaches.
URS occurrence in the study period was comparably 
low,4,6 so another possibility is that insufficient statistical 
power did not reveal a significant relationship between 
increased URS incidence after occurrence of low sIgA 
responses. Sampling in winter may have resulted in more 
recorded URS.4,6 This again implies that a decreased sIgA 
response alone is not enough for subsequent episodes of 
URS. Additional stresses as stated previously26 may be 
necessary to obtain a higher occurrence of URS, which 
is more likely to happen during the winter months.6 It 
is also worth mentioning that there have still been very 
few studies that were able to show a direct link between 
exercise-induced immune depression and increased inci-
dence of confirmed illness in athletes, which therefore 
needs addressing in future studies, although it must be 
recognized that this is difficult.8
Table 2 Influence of Resting Status and the Occurrence of URS Within 2 Weeks on Salivary Data, 
Median (Quartiles) 
Resting status
sIgA secretion rate  
(% from individual median)
sIgA concentration  
(% from individual median)
Saliva flow rate  
(% from individual median)
Same as normal (n = 92) 101 (80, 128) 100 (71, 149) 100 (85, 118)
Worse than normal (n = 30) 92 (72, 120) 98 (74, 121) 100 (91, 120)
Better than normal (n = 3) excluded from analysis excluded from analysis excluded from analysis
Missing data (n = 2) excluded from analysis excluded from analysis excluded from analysis
URS within 2 wk
No (n = 120) 100 (77, 128) 100 (73, 140) 100 (85, 118)
Yes (n = 7) 100 (62, 118) 100 (64, 125) 106 (94, 112)
Abbreviations: URS, upper respiratory symptoms; sIgA, salivary secretory immunoglobulin A. 
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The variation in saliva flow rate was pronounced in 
the studied population; notably, some very low saliva 
flow rates were recorded (eg, participants B, F, J, and N) 
compared with able-bodied athletes.4 We assume that 
this may be population related and due to altered inner-
vation of the salivary glands, which also affects saliva 
flow rate.11 However, it appears that the production of 
sIgA is not affected to the same extent, because on both 
an intraindividual (negative significant relationship) and 
an interindividual (negative nonsignificant relationship) 
comparison, it is evident that sIgA concentration is higher 
in samples with a low saliva flow rate. In line with previ-
ous research in able-bodied populations,2 it may therefore 
be that secretion rate is the more appropriate measure for 
sIgA than concentration in tetraplegic individuals, as it 
takes the pronounced alterations of saliva flow rate in this 
population into account.
Practical Applications
This study found depressions in sIgA secretion rate during 
periods of increased training load in elite tetraplegic 
athletes. Given the higher susceptibility for URS in this 
population, extra care should be taken during periods 
of heavy training to prevent illness. Countermeasures 
include training (ie, allow for adequate recovery) and 
environmental (ie, limit exposure to adverse conditions), 
psychological (ie, monitor stresses), behavioral (ie, 
reduce exposure to common infections), and clinical con-
siderations (ie, conduct pathology testing).26 It is possible 
that some of these strategies have already been adopted 
by the participants on an individual basis, hence resulting 
in the low occurrence of URS in the current study. This 
may have been achieved by avoiding pathogen exposure, 
or by adopting strategies to prevent sIgA reaching levels 
low enough to increase the risk of contracting URS. How-
ever, to investigate the impacts of low sIgA responses on 
URS in the studied population, we encourage others to 
conduct further studies in the winter months to achieve 
a higher occurrence of URS, which would then improve 
the statistical power of the outcomes.
Self-reporting URS has been questioned earlier,8 
and we are aware that because of self-reporting, we may 
have missed or misclassified some episodes of URS. A 
further source of error is the home collection of some of 
the saliva samples. By providing detailed instructions, 
we attempted to prepare our participants optimally to 
provide valid samples and illness reports. However, for 
future studies, we would encourage collaboration with 
trained medical staff for the definition of URS. Further-
more, even though we attempted to limit to a minimum 
the time saliva samples were stored on ice before they 
were frozen, we recommend attempting to reduce this 
time to avoid any potential inaccurate results stemming 
from storage-related sIgA breakdown. In addition, if 
feasible, hydration status should be assessed, as it may 
have an impact on oral-mucosal respiratory immunity.2 
For future studies we further suggest analyzing more 
parameters relating to oral-respiratory mucosal immunity 
(ie, α-amylase, lysozyme, lactoferrin), which may shed 
more light on the interaction of oral immune markers 
and URS.1 Markers of sympathetic nervous activity 
(ie, α-amylase, chromogranin A) may provide further 
information about a mechanistic explanation of findings 
related to oral-respiratory mucosal immune function. 
Finally, the inclusion of a control group would strengthen 
the outcomes of any follow-up study.
Conclusions
Training load in tetraplegic wheelchair rugby athletes is 
negatively associated with sIgA secretion rate, as previously 
observed in able-bodied athletic populations. Furthermore, 
the range and variation of sIgA secretion rate and concen-
tration are comparable to those in the existing able-bodied 
literature. We therefore conclude that a trained tetraple-
gic population’s chronic oral-mucosal immunological 
response to exercise is comparable to that of able-bodied 
athletic populations. However, the nonsignificant rela-
tionship between sIgA and URS occurrence brings into 
question the use of sIgA as a prognostic tool for the early 
detection of upcoming URS in the studied population.
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